BioSpace News Archive

NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, will host a virtual tour of the Nanox.ARC at the RSNA Annual Meeting on December 1, 2021 at 11:30 am EST (10:30 am CST) as previously announced.

MEI Pharma, Inc. today announced the appointment of Mr. Sujay Kango to its board of directors effective November 22, 2021.

Hologic, Inc. (Nasdaq: HOLX) will showcase its extensive portfolio of breast and skeletal health products at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 28 to Dec. 2.

As cold and flu season intensifies across the U.S., global heart health leader OMRON Healthcare, Inc., is issuing a national health alert to the increased risk that a bout with the seasonal flu can have for adults with high blood pressure and other health conditions with increased heart disease risk.

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, will participate in the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the peer-reviewed publication of results from its Phase 3 VANISH-306 study in the International Journal of Obstetrics and Gynaecology (BJOG).

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced that members of its senior management team are scheduled to participate in the following virtual investor conferences in December.

Neurophth Therapeutics Ltd., a fully integrated genomic medicines company dedicated on seeking to improve lives through the curative potential of gene therapies, announced the closing of over $60 million USD in Series-C financing with a premier syndicate of investors, co-led by CMG-SDIC Capital and Sequoia Capital China.

GreenLight Biosciences Inc., an RNA-focused biotech, and Environmental Impact Acquisition Corp. announced an expansion of its PIPE financing to an aggregate $124 million in gross proceeds.

Vivera is pleased to announce the launch of LabPort, a comprehensive software solution designed to streamline and integrate the diagnostic testing and results reporting process for laboratories, employers, and patients.